|
|
||||||||
Radiology, Vol 192, 407-412, Copyright © 1994 by Radiological Society of North America
ARTICLES |
S Sironi, F De Cobelli, T Livraghi, G Villa, A Zanello, G Taccagni and A DelMaschio
Department of Radiology, Scientific Institute S Raffaele, University Hospital, Milan, Italy.
PURPOSE: To determine the value of magnetic resonance (MR) imaging in follow-up of small (< 3 cm) hepatocellular carcinoma treated with percutaneous ethanol injection (PEI). MATERIALS AND METHODS: Fifty- seven patients underwent MR imaging before and after PEI. At follow-up every 6 months, MR images were correlated with results of fine-needle aspiration biopsy (FNAB). In 12 patients, correlation with histologic findings in surgical specimens was possible. RESULTS: In 39 patients followed up for 24 months, the treated lesions showed hypointensity on unenhanced (T2-weighted) images and loss of enhancement on enhanced (T1- weighted) images. At 6-month follow-up in six patients, the lesions showed areas of hyperintensity on unenhanced images and enhancement on enhanced images. These lesions contained residual viable tumor at FNAB. Twelve patients underwent surgical resection after 6-month follow-up. Correct diagnosis of complete or partial tumor necrosis was made in nine of these 12 patients with enhanced images and in three with unenhanced images. CONCLUSION: Gadolinium-enhanced T1-weighted MR imaging is more accurate than unenhanced T2-weighted MR imaging in evaluation of PEI therapy.
This article has been cited by other articles:
![]() |
K. Numata, M. Morimoto, T. Ogura, K. Sugimori, S. Takebayashi, M. Okada, and K. Tanaka Ablation Therapy Guided by Contrast-Enhanced Sonography with Sonazoid for Hepatocellular Carcinoma Lesions Not Detected by Conventional Sonography J. Ultrasound Med., March 1, 2008; 27(3): 395 - 406. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. Numata, T. Isozaki, Y. Ozawa, T. Sakaguchi, T. Kiba, T. Kubota, A. Ito, K. Sugimori, K. Shirato, M. Morimoto, et al. Percutaneous Ablation Therapy Guided by Contrast-Enhanced Sonography for Patients with Hepatocellular Carcinoma Am. J. Roentgenol., January 1, 2003; 180(1): 143 - 149. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. Numata, K. Tanaka, T. Kiba, S. Matsumoto, S. Iwase, K. Hara, H. Kirikoshi, K. Morita, S. Saito, and H. Sekihara Nonresectable Hepatocellular Carcinoma: Improved Percutaneous Ethanol Injection Therapy Guided by CO2-Enhanced Sonography Am. J. Roentgenol., October 1, 2001; 177(4): 789 - 798. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. Dromain, T. de Baere, D. Elias, V. Kuoch, M. Ducreux, V. Boige, P. Petrow, A. Roche, and R. Sigal Hepatic Tumors Treated with Percutaneous Radio-frequency Ablation: CT and MR Imaging Follow-up Radiology, April 1, 2002; 223(1): 255 - 262. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| RADIOLOGY | RADIOGRAPHICS | RSNA JOURNALS ONLINE |